A proteasome-associated autoinflammatory syndrome that is characterized by early childhood onset of annular erythematous plaques on the face and extremities with subsequent development of partial lipodystrophy and laboratory evidence of immune dysregulation and that has_material_basis_in homozygous or compound heterozygous mutation in the PSMB8 gene on chromosome 6p21. Digenic forms of PRAAS1 can be caused by heterozygous mutation in the PSMB8 gene and heterozygous mutation in either the PSMA3 gene on chromosome 14q23 or in the PSMB4 on chromosome 1q21.
The label is preserved as historical source vocabulary and may not map cleanly to current terminology.
Use this page as a research index. Persistent, severe, unexplained or worsening symptoms need appropriate clinical assessment.
The use profile explains the vocabulary and connects related data. It does not establish safe preparation, dose, route, effectiveness or suitability for a modern diagnosis.